DRUG ALBUM PKDHS 2021

DIOSMIN 450MG AND HESPERIDIN
50MG TABLET

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT Due to natural properties of materials,
there may be variation in colour of
tablet from batch to batch

87

DIPHENHYDRAMINE HYDROCHLORIDE
14MG/5ML EXPECTORANT

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Present in breast milk. Not
SPECIAL COUNSELING POINT recommended for breastfeed
This drug may cause CNS depression
(somnolence). If affected, do not drive

or operate machinery

88

DIPHENHYDRAMINE HYDROCHLORIDE
7MG/5ML EXPECTORANT

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Present in breast milk. Not
SPECIAL COUNSELING POINT recommended for breastfeed
This drug may cause CNS depression
(somnolence). If affected, do not drive
or operate machinery. Not for patient

below 2 years old

89

DIPHENOXYLATE HCL 2.5MG WITH
ATROPINE SULPHATE 0.025MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Present in breast milk. Not
SPECIAL COUNSELING POINT recommended for breastfeed
This drug may cause CNS depression
(somnolence). If affected, do not drive

or operate machinery

90

DIPHTHERIA AND TETANUS VACCINE
INJECTION

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT Monitor for any Adverse Effect
Following Immunization (AEFI) in

patient

91

DIPHTHERIA, TETANUS, ACELLULAR
PERTUSSIS, INACTIVATED POLIO VIRUS,

HAEMOPHILUS INFLUENZA TYPE B
(DTAP-IPV-HIB) VACCINE INJECTION

(SINGLE DOSE)

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT Monitor for any Adverse Effect
Following Immunization (AEFI) in

patient

92

DOMPERIDONE 10MG TABLET

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION Present in breast milk.
SPECIAL COUNSELING POINT Domperidone may be associated with
an increased risk of serious ventricular

arrhytmia

93

DOXYCYCLINE 100MG CAPSULE

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT Compatible
Jarish-Herxheimer reaction such as
fever, chill, headache, muscle ache

and skin rash may occur

94

DYDROGESTERONE 10MG TABLET

CATEGORY DESCRIPTION
PREGNANCY Potential risk in human is unknown
LACTATION Present in breast milk. Should not be

SPECIAL COUNSELING POINT used during breastfeed
Some people may experience
breakthrough bleeding when treated

with this medication

95

EAR WAX SOFTENER

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT Discard the drops 6 months after

opening

96

EFAVIRENZ 600MG TABLET

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
Present in breast milk. Not
SPECIAL COUNSELING POINT recommended to breastfeed
Pregnancy should be avoided in
woman receiving this medication

97

ENALAPRIL 10MG TABLET

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
Limited Human Data - Probably
SPECIAL COUNSELING POINT Compatible

Can cause injury and death to the
developing fetus. Discontinue as soon

as possible once pregnancy is
detected

98

ENALAPRIL 20MG TABLET

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
Limited Human Data - Probably
SPECIAL COUNSELING POINT Compatible

Can cause injury and death to the
developing fetus. Discontinue as soon

as possible once pregnancy is
detected

99

ENALAPRIL 5 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D, Human Data Suggest Risk in 2nd and 3rd
SPECIAL COUNSELING POINT Trimesters

Limited Human Data— Probably
Compatible

This drug may cause occasional
dizziness or weariness, if affected, do

not drive or operate machinery.

100

ERYTHROMYCIN ETHYLSUCCINATE 400
MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B
SPECIAL COUNSELING POINT
Compatible

Do not take this medicine if you ever had an
allergic reaction (rashes, breathlessness,

swollen eyes) to Erythromycin or any similar
medicines such as clarithromycin,

azithromycin. DO NOT take Erythromycin
ethylsuccinate with medicines for mood

disorder, migraine, allergies, stomach
disorder and high cholesterol. Avoid alcohol.

101

ERYTHROMYCIN ETHYLSUCCINATE 400
MG/ 5 ML SUSPENSION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B
SPECIAL COUNSELING POINT
Compatible

Do not take this medicine if you ever had an
allergic reaction (rashes, breathlessness,

swollen eyes) to Erythromycin or any similar
medicines such as clarithromycin,

azithromycin. DO NOT take Erythromycin
ethylsuccinate with medicines for mood

disorder, migraine, allergies, stomach
disorder and high cholesterol.

102

ETHAMBUTOL HCL 400 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Limited Human Data—
Probably Compatible

This drug may cause visual
disturbances, if affected, do not drive or

operate machinery.

103

ETHYL CLORIDE 100ML SPRAY

CATEGORY DESCRIPTION
PREGNANCY
LACTATION N – Not classified

SPECIAL COUNSELING POINT There are no data on the excretion of
dichlorotetrafluorethane-ethyl chloride into

human milk.
To protect against tissue sloughing, cover
the skin adjacent to the area being treated
with petrolatum. Avoid spilling the liquid on

the skin. Freezing may also distort the
histological structure of biopsy specimens.
Highly flammable. Avoid inhalation when

used as local anaesthesia.

104

ETONOGESTREL 68 MG IMPLANT

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B3 -Contraindicated: Remove implant if
SPECIAL COUNSELING POINT pregnancy occurs

Limited Human Data— Probably
Compatible

May develop bleeding irregularities.

105

FELODIPINE 10 MG EXTENDED
RELEASE TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Limited Human Data—Animal Data
SPECIAL COUNSELING POINT Suggest Risk

No Human Data—Probably
Compatible

May be taken with or without food.
Take w/o food or w/ a light meal. Avoid

grapefruit juice.

106

FELODIPINE 5 MG EXTENDED RELEASE
TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Limited Human Data—Animal Data
SPECIAL COUNSELING POINT Suggest Risk

No Human Data—Probably
Compatible

May be taken with or without food.
Take w/o food or w/ a light meal. Avoid

grapefruit juice.

107

FENOFIBRATE 145MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
B -limited human data- Animal data
LACTATION suggest risk
SPECIAL COUNSELING POINT
No human data- Potential toxicity

Should be taken with food. Increased
rate of absorption with food.

108

FERROUS CONTROLLED RELEASE 525 MG, VITAMIN
B1, VITAMIN B6, VITAMIN C, NIACINAMIDE,

CALCIUM PANTOTHENATE, FOLIC ACID 800 MCG
TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION A
SPECIAL COUNSELING POINT
Compatible

Absorption inhibited by Mg
trisilicate, dairy products & carbonate-

containing antacids.

109

FERROUS FUMARATE 200 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
Not assigned - Problems in humans
LACTATION have not been
SPECIAL COUNSELING POINT
documented with orally intake of
daily recommended amounts

Problem in humans have not
been documented

Absorption may be decreased when
given with food, particularly cereals,
dietary fibre, coffee tea, eggs and milk.

110

FLUPENTHIXOL DECANOATE 20 MG/ML
INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Should be used with careful monitoring
during breastfeeding

Increases adverse extrapyramidal
symptoms with dopamine antagonists

(metoclopramide and
prochlorperazine).

111

FLUPHENAZINE DECANOATE 25
MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Should be used with careful monitoring
during breastfeeding

Monitor for hypersensitivity reactions
and extrapyramidal dysfunction

112

FLUTICASONE PROPIONATE 125
MCG/DOSE INHALER

CATEGORY DESCRIPTION
PREGNANCY C - Use with caution
LACTATION
SPECIAL COUNSELING POINT Use with caution
Discontinue use if paradoxical
bronchospasm occurs. Not to be used in

acute attacks.

113

FLUVOXAMINE 100MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Human Data Suggest Risk in 3rd
SPECIAL COUNSELING POINT Trimester

Limited Human Data—
Potential Toxicity

Swallow whole, do not chew. This drug
may cause somnolence, if affected, do

not drive or operate machinery.

114

FLUVOXAMINE 50 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Human Data Suggest Risk in 3rd
SPECIAL COUNSELING POINT Trimester

Limited Human Data—
Potential Toxicity

Swallow whole, do not chew. This drug
may cause somnolence, if affected, do

not drive or operate machinery.

115

FOLIC ACID 5 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY A
LACTATION
SPECIAL COUNSELING POINT Compatible
Special Precautions in patients with

folate-dependent tumours.

116

FRUSEMIDE 10 MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Human data suggest low risk

SPECIAL COUNSELING POINT Limited human data- Probably
compatible

This drug may cause reduced mental
alertness, dizziness, and blurred vision,

if affected, do not drive or operate
machinery. Hypotensive effect may be

enhanced by alcohol.

117

FRUSEMIDE 40 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Human data suggest low risk

SPECIAL COUNSELING POINT Limited human data- Probably
compatible

This drug may cause reduced mental
alertness, dizziness, and blurred vision,

if affected, do not drive or operate
machinery. Hypotensive effect may be

enhanced by alcohol.

118

FUSIDIC ACID 2% IN BETAMETHASONE
VALERATE 0.1% CREAM

CATEGORY DESCRIPTION
PREGNANCY
Not Assigned - no or limited data from
LACTATION the use of betamethasone on the skin
SPECIAL COUNSELING POINT of pregnant women. Studies in animals

have shown reproductive
toxicity.

Use with caution

Avoid contact with eyes as it may cause
glaucoma. Avoid extensive use during
pregnancy. Avoid long-term continuous
therapy on face, flexures, intertriginous

areas & in infants & children

119

GLICLAZIDE 30 MG MODIFIED RELEASE
TABLET

CATEGORY DESCRIPTION
PREGNANCY C - Contraindicated
LACTATION
SPECIAL COUNSELING POINT Contraindicated
Increased risk of hypoglycaemia.

120

GLICLAZIDE 60 MG MODIFIED RELEASE
TABLET

CATEGORY DESCRIPTION
PREGNANCY C - Contraindicated
LACTATION
SPECIAL COUNSELING POINT Contraindicated
Increased risk of hypoglycaemia.

121

GLYCERIN 25% AND SODIUM CHLORIDE
15% ENEMA

CATEGORY DESCRIPTION
PREGNANCY C - Use with caution
LACTATION
SPECIAL COUNSELING POINT Use with caution
This medication will cause frequent and

rapid bowel movements. Please be
close to the toilet until the effect of the

medicine runs out

122

GLYCERYL TRINITRATE 0.5 MG
SUBLINGUAL TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Human Data Suggest Low Risk

SPECIAL COUNSELING POINT No Human Data—Probably
Compatible

This drug may cause dizziness, light-
headedness, headache, blurred vision,
and postural hypotension; if affected,

do not drive or operate machinery.

123

INFLUENZA VACCINE INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Limited Human Data—Probably
Compatible

Monitor for hypersensitivity reaction

124

HALOPERIDOL 5 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Limited human data- Animal data
SPECIAL COUNSELING POINT suggest moderate risk

Limited human data- Potential
toxicity

This drug may cause somnolence, if
affected, do not drive or operate

machinery. Avoid exposure to extreme
heat. Avoid strenuous exercise. Ensure

adequate fluid intake to prevent
dehydration.

125

HALOPERIDOL 5 MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Limited human data- Animal data
SPECIAL COUNSELING POINT suggest moderate risk

Limited human data- Potential
toxicity

This drug may cause somnolence, if
affected, do not drive or operate

machinery. Avoid exposure to extreme
heat. Avoid strenuous exercise. Ensure

adequate fluid intake to prevent
dehydration.

126

HEPATITIS B VACCINE INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Limited Human Data—Probably
Compatible

Monitor for hypersensitivity reaction

127

HUMAN PAPILLOMAVIRUS (TYPE 6, 11,
16, 18) VACCINE INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Limited Human Data—Probably
Compatible

Monitor for hypersensitivity reaction

128

HYDROCHLOROTHIAZIDE 25 MG
TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B
SPECIAL COUNSELING POINT
Compatible

This medicine may cause dizziness, if
affected, do not drive or operate

machinery. This medicine may cause
photosensitivity reactions, avoid exposure
to direct sunlight and UV light and apply

sunscreen when going outdoors.

129

HYDROCORTISONE 1% CREAM

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C -Human Data Suggest Risk

SPECIAL COUNSELING POINT Limited Human Data—Probably
Compatible

Apply sparingly to affected area as
directed until condition improve, then

reduce frequency

130

HYDROCORTISONE SODIUM
SUCCINATE 100MG INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C - Human data suggest risk

SPECIAL COUNSELING POINT Limited human data- Probably compatible.
Systemically administered corticosteroids
appear in human milk and could suppress
growth, interfere with endogenous
corticosteroid production, or cause other
untoward effects

Monitor for hypersensitivity reaction

131

HYDROGEN PEROXIDE VOLUME
SOLUTION

CATEGORY DESCRIPTION
PREGNANCY Not assigned
LACTATION Limited Human Data
SPECIAL COUNSELING POINT Monitor for hypersensitivity reaction

132

HYOSCINE N-BUTYLBROMIDE 10 MG

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C -Human data suggest low risk
SPECIAL COUNSELING POINT
Limited human data- Probably compatible

Not to be taken on continuous daily basis or
for extended periods w/o investigating
cause of abdominal pain. Seek medical
advice in case severe, unexplained
abdominal pain persists or worsens
together with symptoms.

133

HYOSCINE N-BUTYLBROMIDE 20
MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C -Human data suggest low risk
Crosses placenta
SPECIAL COUNSELING POINT
Use during labor appears to have a
detrimental effect on newborn infants'

nursing behavior. Longterm use of
scopolamine might reduce milk production or

milk letdown, but a single systemic
is not likely to interfere with breastfeeding

Monitor for hypersensitivity reaction

134

IBUPROFEN 200 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
C - Human Data Suggest Risk in 1st and
LACTATION 3rd Trimesters
SPECIAL COUNSELING POINT Compatible

Increased risk of gastrointestinal
ulceration, perforation or haemorrhage

with other NSAIDs. Should be taken
with food.

135

INSULIN ASPART 30% AND PROTAMINATED
INSULIN ASPART 70% 100 IU/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT Compatible
Should be taken with food: Administer

immediately before or soon after a
meal.

136